Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
115.09
+4.30 (3.88%)
At close: Apr 28, 2026, 4:00 PM EDT
115.90
+0.81 (0.70%)
After-hours: Apr 28, 2026, 4:28 PM EDT

Company Description

Nutex Health Inc. operates as a healthcare services and operations company in the United States.

It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health.

It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies.

The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs.

The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.

Nutex Health Inc.
Nutex Health logo
Country United States
Founded 2011
Industry Medical Care Facilities
Sector Healthcare
Employees 944
CEO Thomas Vo

Contact Details

Address:
1776 Yorktown Street, Suite 700
Houston, Texas 77056
United States
Phone 713 660 0557
Website nutexhealth.com

Stock Details

Ticker Symbol NUTX
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001479681
CUSIP Number 67079U306
ISIN Number US67079U3068
Employer ID 11-3363609
SIC Code 7389

Key Executives

Name Position
Dr. Thomas T. Vo M.B.A., M.D. Chairman of the Board and Chief Executive Officer
Dr. Warren Hosseinion M.D. President and Director
Jon C. Bates CPA, M.B.A. Chief Financial Officer
Wesley Bamburg FACHE Chief Operating Officer
Dr. Michael Chang M.D. Chief Medical Officer
Jennifer Rodriguez Investor and Public Relations Manager
LaTanya Brackens Director of Compliance
Vivian Sanders M.B.A. Director of Marketing
Sarah Wallace Director of Human Resources
Elisa Michael Luqman Esq., J.D., M.B.A. Chief Legal Officer of SEC

Latest SEC Filings

Date Type Title
Apr 27, 2026 SCHEDULE 13G Filing
Apr 23, 2026 8-K Current Report
Mar 13, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 13, 2026 DEF 14A Other definitive proxy statements
Mar 12, 2026 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 10, 2026 SCHEDULE 13G Filing
Mar 9, 2026 S-8 Securities to be offered to employees in employee benefit plans
Mar 5, 2026 8-K Current Report
Mar 5, 2026 10-K Annual Report
Feb 11, 2026 SCHEDULE 13G/A Filing